First, transparency about the evidence gap
We had to understand the analytical science inside and out
Research Use Only: Not for human or veterinary therapeutic applications
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Carnitine, National Institutes of Health (2023) Effects of three treatment modalities (diet, myoinositol, or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome, European Review for Medical and Pharmacological Sciences (2019) Who can perform semaglutide treatments?, American Med Spa Association (2023) Using fat-dissolving injections that are not FDA-approved can be harmful, U.S
Tracking your results Objective tracking separates productive research from guesswork
By combining these mechanisms, tirzepatide effectively lowers blood glucose levels, aids in weight loss, and improves overall metabolic health in individuals with type 2 diabetes